A deeper map of a critical brain circuit
Researchers participating in the U.S. BRAIN Initiative have produced a three-dimensional atlas of the human basal ganglia that combines single-cell genetic and epigenetic detail. The work appears as a collection of 28 papers across Cell Press journals, according to the Salk Institute.
The basal ganglia are groups of nerve cells located deep in the brain. They are involved in learning, emotion and movement, making them central to both everyday behavior and a range of neurological disorders. Dysfunction in these circuits has been associated with Parkinson’s disease, Huntington’s disease, Tourette syndrome and addiction.
The new resource is intended to give researchers a more detailed way to identify cells in this region of the human brain and to understand how genes are regulated within them. Rather than viewing the basal ganglia as a single structure, the atlas aims to distinguish individual cell types and connect them with genetic and epigenetic information.
Why single-cell detail matters
Brain tissue contains many kinds of cells, and cells occupying the same broad anatomical region can differ sharply in their roles and in the genes they use. A cell-by-cell atlas can help researchers ask more precise questions: which cell types are implicated by a genetic risk signal, how are their genes regulated, and where might an intervention act?
The Salk Institute describes the database as a way to identify and pinpoint each cell in the human basal ganglia. Its inclusion of epigenetic information is particularly relevant because epigenetics concerns mechanisms that influence gene activity without changing the underlying DNA sequence.
That level of resolution does not immediately translate into a treatment. It does, however, provide a shared reference for researchers working across brain science, genetics and disease biology. Better maps can make it easier to compare findings from separate studies and to test whether a signal observed in one dataset corresponds to a specific cell population in human tissue.
A BRAIN Initiative collaboration
The atlas is part of the Brain Research Through Advancing Innovative Neurotechnologies Initiative, or BRAIN Initiative, a large collaboration launched in 2014 to advance understanding of the human brain. The project also belongs to the BRAIN Initiative Cell Atlas Network, known as BICAN, which focuses on mapping brain cells and circuits across multiple species with an emphasis on humans.
Salk researchers contributed epigenetic expertise to the effort. Margarita Behrens, a research professor at Salk and senior author on multiple papers in the package, characterized BICAN as a collaborative effort to identify and characterize brain cells one by one. That long-term ambition illustrates the scale of the atlas project: it is not simply a visualization of anatomy, but an expanding catalog of cellular identity and regulation.
Publishing the findings across 28 papers also reflects the breadth of the effort. A resource of this kind needs methods for classifying cells, integrating data and interpreting genetic and epigenetic patterns, along with scientific questions that show why those distinctions matter.
Potential relevance to neurological disease
Because the basal ganglia participate in movement, adaptive behavior and emotion, a detailed cellular map could be useful for several areas of disease research. Parkinson’s and Huntington’s disease, Tourette syndrome and addiction are all named by the Salk Institute as conditions connected to basal-ganglia dysfunction.
The atlas may help investigators link genetic risk to particular cell types. That is an important step between a broad statistical association and a clearer biological hypothesis. If researchers can identify which cells carry a relevant pattern of gene regulation, they may be better placed to study how disease processes begin or progress.
The Salk summary also says the resource could inform more targeted therapeutic work, including the identification of genetic and epigenetic targets relevant to gene-editing approaches. Such applications remain future possibilities, not outcomes demonstrated by the atlas itself. Developing a treatment requires much more than locating a target: researchers must establish safety, efficacy, delivery and the consequences of changing activity in a specific cell population.
A reference for research beyond one disorder
Joseph Ecker, a Salk professor and senior author of multiple papers in the BICAN package, said the long-term hope is to create a reference that can be used by scientists across fields, including cancer, Alzheimer’s disease and neurodevelopmental disorders. The goal is to help researchers understand the cells involved and how they might be manipulated to prevent or treat disease and decline.
That broader aspiration is a reminder that atlases are infrastructure for science. Their immediate output is organized knowledge: where cells are, how they differ and how their genes are regulated. Their downstream impact depends on whether researchers can use that knowledge to frame stronger experiments and identify interventions with real clinical value.
For the basal ganglia, the new atlas offers a substantially finer view of a brain system that has long been important to movement and psychiatric research. It does not resolve the causes of the disorders linked to this circuitry. But by providing single-cell genetic and epigenetic detail in a three-dimensional human reference, it gives scientists a more specific starting point for addressing them.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
